Insider Transactions
Showing insider trading activity for STRECK PAUL.
Insider Trading Activity Chart
Visualizing insider transactions on stock price candles
Transaction Type
Insider Role
Min Transaction Value
No stock price data available.
Recent Filings
| Symbol | Name | Filed | Transaction | Type | Role | Shares |
|---|---|---|---|---|---|---|
| PEPG | STRECK PAUL | 6 Mar 2026 | 4 Mar 2026 | S-Sale | EVP, Head of R&D | 1,832 |
| PEPG | STRECK PAUL | 6 Mar 2026 | 4 Mar 2026 | S-Sale | EVP, Head of R&D | 47 |
| PEPG | STRECK PAUL | 2 Mar 2026 | 1 Mar 2026 | A-Award | EVP, Head of R&D | 196,500 |
| PEPG | STRECK PAUL | 2 Mar 2026 | 1 Mar 2026 | A-Award | EVP, Head of R&D | 50,300 |
| PEPG | STRECK PAUL | 18 Dec 2025 | 4 Nov 2025 | D-Return | EVP, Head of R&D | 202,816 |
| PEPG | STRECK PAUL | 18 Dec 2025 | 4 Nov 2025 | A-Award | EVP, Head of R&D | 202,816 |
| PEPG | STRECK PAUL | 18 Dec 2025 | 4 Nov 2025 | D-Return | EVP, Head of R&D | 40,000 |
| PEPG | STRECK PAUL | 18 Dec 2025 | 4 Nov 2025 | A-Award | EVP, Head of R&D | 40,000 |
| PEPG | STRECK PAUL | 2 Jun 2025 | 30 May 2025 | P-Purchase | EVP, Head of R&D | 8,375 |
| PEPG | STRECK PAUL | 5 Mar 2025 | 3 Mar 2025 | A-Award | EVP, Head of R&D | 87,000 |
| PEPG | STRECK PAUL | 5 Mar 2025 | 3 Mar 2025 | A-Award | EVP, Head of R&D | 19,430 |
| PEPG | STRECK PAUL | 20 Aug 2024 | 19 Aug 2024 | A-Award | EVP, Head of R&D | 40,000 |
| PEPG | STRECK PAUL | 20 Aug 2024 | 19 Aug 2024 | A-Award | EVP, Head of R&D | 202,816 |
| PEPG | STRECK PAUL | 20 Aug 2024 | 19 Aug 2024 | officer | 0 | |
| ALBO | STRECK PAUL | 2 Mar 2023 | 2 Mar 2023 | D-Return | Chief Medical Officer | 118,966 |
| ALBO | STRECK PAUL | 27 Jan 2023 | 19 Jan 2023 | A-Award | Chief Medical Officer | 55,000 |
| ALBO | STRECK PAUL | 25 Jan 2023 | 19 Jan 2023 | A-Award | Chief Medical Officer | 55,000 |
| ALBO | STRECK PAUL | 21 Dec 2022 | 19 Dec 2022 | A-Award | Chief Medical Officer | 63,966 |
| ALBO | STRECK PAUL | 21 Dec 2022 | 19 Dec 2022 | officer | 0 | |
| ALBO | STRECK PAUL | 21 Dec 2022 | 19 Dec 2022 | — | — |